Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Revised SOPs for Aerosols V 2.0

Aerosol: SOP for Line Clearance Before Starting Aerosol Manufacturing – V 2.0

Posted on By

This Standard Operating Procedure (SOP) defines the procedure for line clearance before starting aerosol manufacturing. The purpose is to ensure that all previous products, materials, and contamination are completely removed from the production line before starting a new batch. This process helps in preventing cross-contamination, ensuring product quality, and complying with GMP (Good Manufacturing Practice) requirements.
Click to read the full article.

Aerosols V 2.0

Aerosol: SOP for Documenting Deviation Reports During Manufacturing – V 2.0

Posted on By

This Standard Operating Procedure (SOP) defines the process for documenting deviation reports during aerosol manufacturing. The objective is to ensure that any deviations from standard operating procedures, specifications, or expected results during production are identified, documented, investigated, and resolved appropriately. Proper documentation of deviations helps maintain product quality, ensures compliance with GMP guidelines, and provides a basis for corrective actions and continuous improvement.
Click to read the full article.

Aerosols V 2.0

Aerosol: SOP for Review and Approval of Batch Manufacturing Records – V 2.0

Posted on By

This Standard Operating Procedure (SOP) defines the process for reviewing and approving batch manufacturing records (BMR) during aerosol production. The purpose is to ensure that all manufacturing activities, including raw material usage, process parameters, and product testing, are documented and reviewed for compliance with quality standards and regulatory requirements. Proper review and approval of BMRs ensure that the final product meets specifications and is safe for release.
Click to read the full article.

Aerosols V 2.0

Aerosol: SOP for Conducting Internal Audits in Aerosol Manufacturing – V 2.0

Posted on By

This Standard Operating Procedure (SOP) defines the process for conducting internal audits in aerosol manufacturing. The objective is to ensure that all aspects of the manufacturing process comply with company policies, GMP regulations, and industry standards. Internal audits are essential for identifying non-compliance issues, areas for improvement, and ensuring ongoing product quality and safety.
Click to read the full article.

Aerosols V 2.0

Aerosol: SOP for Handling Complaints Related to Aerosol Products – V 2.0

Posted on By

This Standard Operating Procedure (SOP) outlines the process for handling complaints related to aerosol products. The objective is to ensure that all customer complaints are addressed in a timely and effective manner, with corrective actions taken as necessary to maintain product quality and customer satisfaction. Proper handling of complaints helps in identifying potential quality issues and preventing recurrence.
Click to read the full article.

Aerosols V 2.0

Aerosol: SOP for Risk Assessment in Aerosol Manufacturing – V 2.0

Posted on By

This Standard Operating Procedure (SOP) defines the process for conducting risk assessments in aerosol manufacturing. The objective is to identify potential risks in the manufacturing process, assess their impact, and implement control measures to minimize the likelihood of product defects, equipment failures, safety hazards, and environmental risks. Risk assessment helps in ensuring compliance with GMP and maintaining the safety and quality of aerosol products.
Click to read the full article.

Aerosols V 2.0

Aerosol: SOP for Review of Cleaning Validation Data – V 2.0

Posted on By

This Standard Operating Procedure (SOP) defines the process for reviewing cleaning validation data in aerosol manufacturing. The purpose is to ensure that the cleaning process for equipment used in aerosol production is effective in removing residues of active ingredients, excipients, and contaminants to an acceptable level. Proper review of cleaning validation data ensures compliance with GMP and product safety standards.
Click to read the full article.

Aerosols V 2.0

Aerosol: SOP for QA Oversight During Manufacturing Operations – V 2.0

Posted on By

This Standard Operating Procedure (SOP) outlines the responsibilities of Quality Assurance (QA) during aerosol manufacturing operations. The objective is to ensure that the manufacturing process is carried out in compliance with GMP regulations and that the quality of the finished aerosol products meets company standards and regulatory requirements. QA oversight helps identify and mitigate risks during production, ensuring the safety, efficacy, and quality of the product.
Click to read the full article.

Aerosols V 2.0

Aerosol: SOP for Ensuring Compliance With cGMP Standards – V 2.0

Posted on By

This Standard Operating Procedure (SOP) defines the process for ensuring compliance with current Good Manufacturing Practices (cGMP) standards during aerosol manufacturing operations. The objective is to ensure that all aspects of production meet regulatory requirements and industry standards for product safety, efficacy, and quality. Adhering to cGMP guidelines minimizes the risk of contamination, error, and non-compliance with regulatory authorities.
Click to read the full article.

Aerosols V 2.0

Aerosol: SOP for Releasing Finished Aerosol Products – V 2.0

Posted on By

This Standard Operating Procedure (SOP) outlines the process for releasing finished aerosol products for distribution. The objective is to ensure that only products that meet established quality standards, including safety, efficacy, and regulatory compliance, are released for sale. The release process ensures that all necessary checks, documentation, and approvals are completed before a product reaches the customer.
Click to read the full article.

Aerosols V 2.0

Posts pagination

Previous 1 … 8 9 10 … 14 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme